Does TREPROSTINIL Cause Therapy interrupted? 413 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 413 reports of Therapy interrupted have been filed in association with TREPROSTINIL (TYVASO). This represents 0.5% of all adverse event reports for TREPROSTINIL.
413
Reports of Therapy interrupted with TREPROSTINIL
0.5%
of all TREPROSTINIL reports
21
Deaths
223
Hospitalizations
How Dangerous Is Therapy interrupted From TREPROSTINIL?
Of the 413 reports, 21 (5.1%) resulted in death, 223 (54.0%) required hospitalization, and 5 (1.2%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 413 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which TREPROSTINIL Alternatives Have Lower Therapy interrupted Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE